Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Astrana Health Inc.

Company price
None USD 0.00(0%)
Last update at 2024-06-04T03:31:40.429333Z
Market Cap
0.00M

Momentum Score

…

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
35.96
Low
45.71
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
0.41
ROE
-
Net Debt
-58.66M
ROCE
14.59%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 86.62M 77.75M 178.43M 25.84M 82.63M
Minority interest 1.48M 24.56M 84.45M 3.56M 49.43M
Net income 49.05M 49.29M 122.32M 14.12M 10.84M
Selling general administrative 77.67M 62.08M 49.12M 41.48M 43.35M
Gross profit 193.31M 171.23M 143.01M 87.60M 153.55M
Reconciled depreciation 17.54M 17.52M 18.35M 18.75M 19.30M
Ebit 104.27M 98.18M 80.50M 32.42M 86.99M
Ebitda 133.35M 109.21M 106.44M 50.85M 106.29M
Depreciation and amortization 29.09M 11.03M 25.93M 18.43M 19.30M
Non operating income net other -9.73M -15.04M 107.42M -1.85M -5.24M
Operating income 104.27M 98.18M 80.50M 32.42M 88.43M
Other operating expenses 1033.73M 669.20M 601.72M 521.00M 422.45M
Interest expense 7.92M 5.39M 9.50M 4.73M 0.56M
Tax provision 36.09M 28.45M 56.11M 8.17M 22.36M
Interest income 1.98M 1.57M 2.81M 2.02M 1.26M
Net interest income -5.94M -3.82M -6.69M -2.71M 0.70M
Non recurring - - - 0.63M 7.69M
Income tax expense 36.09M 28.45M 56.11M 8.17M 22.36M
Total revenue 1138.00M 767.37M 682.23M 555.41M 514.68M
Total operating expenses 89.05M 73.05M 62.51M 53.19M 61.32M
Cost of revenue 944.68M 596.14M 539.21M 467.80M 361.13M
Total other income expense net -17.65M -20.43M 97.92M -6.58M -10.30M
Net income from continuing ops 50.53M 49.29M 122.32M 17.67M 60.27M
Net income applicable to common shares 49.05M 73.86M 37.87M 14.12M 10.84M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 933.36M 963.90M 852.36M 817.49M 728.71M
Intangible assets 71.65M 76.86M 82.81M 86.98M 103.01M
Other current assets 17.45M 14.80M 85.85M 16.75M 10.39M
Total liab 522.59M 395.21M 336.36M 372.34M 367.65M
Total stockholder equity 614.22M 552.82M 454.55M 330.82M 191.55M
Deferred long term liab - 3.04M 9.13M 10.96M 18.27M
Other current liab 125.60M 84.39M 40.19M 42.05M 54.63M
Common stock - 0.05M 0.04M 0.04M 0.04M
Capital stock 0.05M 0.05M 0.04M 0.04M 0.04M
Retained earnings 243.13M 192.68M 143.63M 69.77M 31.90M
Other liab - 23.30M 23.90M 10.96M 18.27M
Good will 278.83M 275.68M 253.04M 239.05M 238.51M
Other assets - 6.06M 6.50M 55.29M 2.43M
Cash 293.81M 288.03M 233.10M 193.47M 103.19M
Total current liabilities 218.67M 147.33M 115.37M 114.99M 105.42M
Current deferred revenue - 0.53M 16.80M 12.99M 8.89M
Net debt - -58.66M -32.11M 67.08M 153.36M
Short term debt - 4.79M 3.90M 14.17M 12.59M
Short long term debt 19.50M 0.62M 0.78M 10.89M 9.50M
Short long term debt total - 229.36M 200.98M 260.56M 256.55M
Other stockholder equity - 360.10M 310.88M 261.01M 159.61M
Property plant equipment - 128.98M 68.63M 48.46M 26.38M
Total current assets 461.51M 435.14M 398.78M 338.58M 329.07M
Long term investments 32.17M 40.30M 42.61M 47.92M 28.43M
Net tangible assets - 213.97M 118.70M 119.02M 18.76M
Short term investments 2.50M 5.57M 53.42M 67.69M 116.54M
Net receivables 135.76M 126.75M 93.63M 60.66M 98.95M
Long term debt 258.94M 203.39M 182.92M 230.21M 232.17M
Inventory - - -67.22M - -
Accounts payable 9.07M 57.63M 54.48M 45.78M 29.31M
Noncontrolling interest in consolidated entity - 2.19M 5.94M 0.09M 0.79M
Accumulated other comprehensive income - - - - -16.02M
Common stock total equity - 0.05M 0.04M 0.04M 0.04M
Retained earnings total equity - 192.68M 143.63M 69.77M 31.90M
Non currrent assets other 2.22M 6.06M 5.93M 19.41M 2.43M
Non current assets total 471.85M 528.77M 453.58M 478.91M 399.64M
Capital lease obligations 42.58M 25.36M 17.29M 19.45M 14.88M
Long term debt total - 203.39M 182.92M 230.21M 232.17M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 34.28M 32.37M 107.96M -129.70M -23.61M
Change to liabilities 18.80M 3.22M 6.82M -13.88M -10.11M
Total cashflows from investing activities -7.11M 16.54M 95.49M -180.63M -25.18M
Net borrowings -0.83M -57.97M -0.10M 281.35M 7.41M
Total cash from financing activities -20.09M -47.75M -51.70M 163.33M -11.18M
Change to operating activities 36.13M -18.20M -1.22M -21.51M -48.54M
Net income 50.53M 49.29M 122.32M 17.67M 60.27M
Change in cash 54.93M 39.13M 89.96M -3.63M -10.86M
Begin period cash flow 233.10M 193.97M 104.01M 107.64M 118.50M
End period cash flow 288.03M 233.10M 193.97M 104.01M 107.64M
Total cash from operating activities 82.13M 70.33M 46.16M 13.67M 25.50M
Issuance of capital stock 0.00M 40.13M 0.00M 0.75M 0.20M
Depreciation 17.54M 17.52M 18.35M 18.75M 19.30M
Other cashflows from investing activities -18.46M 0.06M -11.30M -49.89M -0.41M
Dividends paid -14.03M -31.09M -51.32M -61.72M 17.76M
Change to inventory - - -5.81M -29.56M -11.76M
Change to account receivables -36.96M -21.63M 3.01M 9.28M -28.63M
Sale purchase of stock -9.25M -5.74M -0.54M -7.57M -5.05M
Other cashflows from financing activities 7.62M 187.48M -1.04M 286.98M 12.02M
Change to netincome -3.71M -2.00M -106.67M 2.27M 8.97M
Capital expenditures 22.94M 19.22M 1.16M 1.04M 1.17M
Change receivables -28.77M -26.80M 15.60M -5.80M -28.63M
Cash flows other operating 26.80M 4.92M -11.61M -5.34M -24.31M
Cash and cash equivalents changes 54.93M 39.13M 89.96M -3.63M -10.86M
Change in working capital -9.58M -20.12M 10.81M -22.77M -63.05M
Stock based compensation 16.10M 6.75M 3.38M 1.55M 1.44M
Other non cash items 15.22M 22.85M -102.08M 5.27M 15.88M
Free cash flow 59.19M 51.11M 45.00M 12.63M 24.33M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
HCA
HCA Healthcare, Inc.
15.19
3.30%
475.52 14.27 13.46 1.21 291.34
THC
Tenet Healthcare Corporation
-0.10
0.04%
263.49 10.08 12.66 0.96 4.57
FSNUY
Fresenius SE & Co KGaA ADR
-0.22
1.52%
14.00 16.87 9.44 0.42 0.78
JDHIY
JD Health International Inc
1.31
30.75%
5.57 62.50 35.97 0.30 2.32

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…